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Abstract
GPCR regulates numerous diverse physiological processes relevant to diabetes, obesity,
Alzheimer's diseases, and several central nervous system disorders and targets proteins in signaling
pathways. It has created nearly 200 billion profits from its derivative drugs in 2018. There are near
400 structures of over 70 GPCRs have been resolved by X-ray crystallography, cryo-electron
microscopy, and NMR spectroscopy. One of the current challenges that remain in the
conformational transition and dynamics study using NMR spectroscopy is to obtain sufficient
quantities of the G proteins and GPCRs. Pichia pastoris has shown its tremendous promise in
expressing the GPCRs in a high yield, along with isotopic labeling capacity for NMR studies.
However, additional work is needed to reach the quantity requirement for most of the receptors.
On the other hand, the mammalian system and insect cell expression systems require a higher cost
of producing G proteins and GPCRs and it is still challenging for isotopic labeling. In this regard,
this thesis is focused on developing and optimizing an applicable P. pastoris expression system
for G proteins particularly to reach certain quantities required for NMR studies. In the meantime,
a fluorine-19 screening was also performed to search for a next-generation fluorine-19 tag in
probing GPCR conformational states at a higher resolution than the current state-of-the-art probe
BTFMA. Through two-year work, we successfully established platforms for preparing yeastderived G proteins, including G and G, which should be sufficient to conduct NMR studies.
Though we are still exploring a next-generation

19 F

probe, the current screening has given us

several promising hits.
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Chapter One: Next Generation 19F probe Screening for GPCR Conformational Profiling
1.1 Introduction
GPCR regulates numerous diverse physiological processes relevant to diabetes, obesity,
Alzheimer's diseases, and several central nervous system disorders and targets proteins in signaling
pathways, already create nearly 200 billion profits from its derivative drugs in 2018. [1-3] GPCRs
are a large family of cell surface receptors that play various roles in the signaling pathways. As
their name indicates that GPCR can interact with G proteins triggered by a conformational change
upon an extracellular molecule binding. The initial signal received by GPCR will pass to
heterotrimeric G protein, which results in conformational changes of G proteins, allowing the
nucleotide exchange with a consequence of dissociation between the Gα and the Gβγ subunits. [46] There are two principal signal transduction pathways involving the G protein-coupled receptors:
G protein and β-arrestin. [7, 8] GPCR can be characterized based on sequence and function: Class
A – rhodopsin-like receptors, Class B-secretin family, Class C-metabotropic glutamate receptors,
Class D-fungal mating pheromone receptors, Class E-cAMP receptors, and Class F-frizzled (FZD)
and smoothened (SMO) receptors. [9] The adenosine A2A receptor belongs to Class A and has been
chosen since it’s a prototypical class A G protein-coupled receptor. [10] The corresponding G
protein subunit is Gαs. [6, 11] Radioligand binding assay is a common method we use to determine
the activity of receptors by measures the affinity of the isotopic labels ligand for a receptor and it
has been used here to measure the activity of G protein base on the change of activity of the
receptor. [12]
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With the advancement of X-ray crystallography and cryo-electron microscopy (cryo-EM), so far,
there are over 400 structures of 70 GPCRs have been resolved. [13, 14] . These resolved threedimensional structures have dramatically promoted drug designing and discovery. [15] Recent
publications revealing structures of GPCRs by X-ray as well established the foundation of the
molecular mechanism of GPCRs’ activation, facilitating the structure-based drug discovery and
providing more reliable models for many other ligand-mediated GPCRs.[16] The structure of the
adenosine A2A receptor revealed by X-ray has successfully been elucidated with the extracellular
loop (ECL2) included. [15] However, the difference while using X-ray or NMR spectrum in both
binding mode and location of the adenosine A2A receptor-ligand suggests that there may be still
having limitations on the direct use of X-ray structures as templets for GPCRs. [15, 16] X-rays can
determine the structures of GPCRs while the Cryo-EM can determine GPCRS coupled to either
heterotrimeric G proteins (Gαi, Gαs or Gαo) or mini-G proteins (mini-Gαs or mini-Gαo). [13, 17]
However, both X-ray and cryo-EM were unable to elucidate the dynamics of protein-protein
interactions or individual proteins. In this regard, Nuclear Magnetic Resonance (NMR)
Spectroscopy is one of the most powerful biophysical tools. [18, 19] Base on this theory, one of
our experiments takes advantage of the change of the resonance frequency which can give details
of the electronic structure of sample molecules. It has been reported that the 19F is the third most
sensitive NMR nucleus to the microenvironmental changes, right after tritium and 1H. [20] [21]
To compare the chemical shift differences of different compounds, the NaF is used as a reference
for free

19F-tag

screening. [13, 19] So far, BTFMA (2-Bromo-N-(4-(trifluoromethyl)phenyl)

acetamide) is the most sensitive tri-fluorinated

19 F-tag

used for profiling receptor confirmation

with the state-of-the-art resolution, but the overlapping of different conformational states is still
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an existing issue, which inspired us to initiate this project to screen the next-generation 19F-tag
with a higher resolution. [22, 23]

To study the conformation and dynamics of GPCRs, this study is to compare the chemical shift
sensitivity of cysteine-specific trifluoromethyl probes in free tags states. The previous study
indicated that it was able to use 19F signal viability of a trifluoromethyl chemical equilibrium to
probe the domain rotation in GPCR based on its sensitivity to microenvironmental changes,
including the change due to receptor conformational change from ligand binding. [22-24] It also
indicates the V229C on transmembrane domain VI (TM6) of adenosine A2a receptor (as shown in
Figure 1) is a desirable labeling site. [10, 25] Since the use of probes with relatively small chemical
shift anisotropy (CSA) is important to the study of protein states in 19F NMR studies. [22, 25] In
this study, trifluoromethyl chemicals were predicted based on their molecular structures comparing
to the BTFMA. [22, 25] We were anticipating obtaining a 19F probe better than the current BTFMA
tag in probing the GPCR conformational states with a higher resolution by exhibiting effective
chemical shift dispersion. The selected ones in free tag screening will be verified via labeling
adenosine A2A receptors by conjugating to the site of V229C.
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Figure 1. GPCR structure: A2A adenosine receptor with V229C

1.2.1 A2AR expression and purification
The construct of pPIC9K_ADORA2A was kindly provided by T.Kobayashi (Japan), which was a
recombinant vector containing the ADORA2A receptor sequence. [26] A pre-cultured single
colony derived stock spread on YPD (1% (w/v) yeast extract, 2% (w/v) peptone and 2% (w/v)
glucose) plates containing 1 mg/mL G418 was inoculate into 4 mL YPD medium and cultured at
30 °C overnight with shaking (275 rpm). Then, transferred into 200 mL BMGY (1% (w/v) yeast
extract, 2% (w/v) peptone, 1.34% (w/v) YNB (yeast nitrogen base) without amino acids, 0.00004%
(w/v) glycerol and 0.1 M PB (phosphate buffer) pH 6.5) medium in 14 mL Falcon tubes at 30 °C
4

for at least 24 h with shaking (275 rpm) until the absorbance of A595nm in the range of 2 to 6. The
medium was then transferred into 1 L BMMY medium (1% (w/v) yeast extract, 2% (w/v) peptone,
1.34% (w/v) YNB (yeast nitrogen base) without amino acids, 0.00004% (w/v) biotin, 0.1 M PB
(phosphate buffer) pH 6.5, 0.04% (w/v) histidine, 3% (v/v) DMSO and 10 mM theophylline) at
20 °C for 60 h with shaking (275 rpm). Methanol (0.5% (v/v)) was added into the medium every
12 h to induce the adenosine A2A receptor expression. [23, 27] 10x phosphate buffer (49.7 g
Na2HPO4 and 98.0 g NaH2PO4 in 10000 mL D2O, pH 6.5) was prepared in ahead.

Figure 2. Purification and labeling flowchart for adenosine A2A receptor
As shown in Figure 2, the cell pellets were collected by centrifuge at 3,800 × g for 10 min at 4 °C
in 400 mL centrifuge bottles and then washed with Common washing buffer P1 (20 mM Bis-Tris,
pH 6.5 or 50 mM HEPES, pH 7.4). Then the cell pellets were resuspended into Receptor Lysis
Buffer P2 (20 mM Bis-Tris, pH 6.5 or 50 mM HEPES, pH 7.4, 2.5 mM EDTA, 10% Glycerol) at
a ratio of four times the volume of cell pellets itself. The cells in P2 were broken via Microfluidizer
for four cycles on the ice at 15,000 psi and centrifuge at 9,720 × g for 30 min at 4 °C in 250 mL
centrifuge bottles to get rid of cell debris. The membrane supernatant was collected and centrifuged
at 100,000 × g for 75 min using T45 rotor for the Beckman Ultracentrifuge, and the precipitated
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cell membrane was then immediately dissolved in Receptor Preparation Buffer P3 (20 mM BisTris, pH 6.5 or 50 mM HEPES, pH 7.4, 100 mM NaCl, 1% MNG-3 and 0.02% CHS (cholesterol
hemisuccinate)) at 4 °C with shaking until dissolved sufficiently. [27, 28]

The dissolved membranes were centrifuged at 1,980 × g for 5 min at 4 °C to get rid of undissolved
ones and then bind to Receptor preparation washing buffer P4 (20 mM Bis-Tris, pH 6.5 or 50 mM
HEPES, pH 7.4, 100 mM NaCl, 0.1% MNG-3, 0.002% CHS) pre-balanced Talon Resin for 2 h at
4 °C with shaking. The amount of resin usage for a 6 g membrane should be around 2 mL. Then,
the Talon Resin can be packed onto a column and performed His-tag purification. First, using
Receptor preparation washing buffer P4 wash on column 5 column volumes and then eluted the
expressed protein, which supposed to be adenosine A2A receptor (35.1 kDa), strategically recycling
using 10 mL Column Elution Buffer P5 (20 mM Bis-Tris, pH 6.5 or 50 mM HEPES, pH 7.4, 100
mM NaCl, 0.1% MNG-3, 0.002% CHS and 300 mM Imidazole) at a gravity rate. [29] Use Ultra15 Centrifuge filters 3K to concentrate the collected eluted receptors to 1 mL and wash the sample
once with 10 mL Receptor preparation washing buffer P4 at 4 °C at 3,846 × g. The concentrated
sample goes through Receptor preparation washing buffer P4 pre-balanced XAC ligand column
three times. The XAC column was washed with 2 column volume Receptor preparation washing
buffer P4. Elute receptor with 8 mL Receptor preparation washing buffer P4 containing 25 mM
theophylline, which is also called XAC Column Elution Buffer P6. The first 2 mL XAC Column
Elution Buffer were eluted directly, while the rest of them needs incubation for 20 min before
elution. Use Ultra-15 Centrifuge filters 3K to concentrate the collected eluted receptors to 1 mL
and wash the sample once with 10 mL Receptor preparation washing buffer P4 at 4 °C, 3,846 × g.
1.2.2 19F NMR experiments for free tri-fluorinated compounds
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To evaluate the sensitivity of each potential tag to microenvironmental changes, a series of
methanol/water mixtures were prepared with a range from (MeOH: H2O = 4) to (MeOH: H2O =
1/4) to create a polarity screening system, mimicking micro-electrostatic environment. [22, 23]
NMR experiments were performed on a 600 MHz spectrometer with a

19 F

spectroscopy probe.

Chemical shift sensitivity was measured at 20 °C with reference NaF at (-119 ppm) and spectra
were collected and processed by MestReNova. [25, 30]

1.2.3 19F NMR experiments on 19F labeled A2AR receptor
The previous study revealed that the BTFMA tag exhibited a significantly greater range of
chemical shifts as a function of solvent polarity. [31] BTFMA use as the sample of NMR labeling
at a final concentration of 1 mM here. The mixture of Talon Resin containing expressed receptors
was conjugated with the BTFMA label and incubated at 4 °C with gently shaking for 36 h via
adding BTFMA every 12 h to ensure the labeling efficiency before performing standard His-tag
purification as described in 1.2.1 [12, 23]. The 19F NMR experiments were conducted at 20°C on
the DD600 variant Spectrometer equipped with a 19F probe.

1.2.4 SDS-PAGE
Preparing the SDS-PAGE gel base on the size of protein and our choice is 12% for separating and
6% for stacking gel. The purified protein mixture to the 2 × loading (50 mL receipt: 1 mg
bromophenol blue, 12.5 mL 1.5 M Tris-HCl, pH 6.8, 2.5 mL10% SDS (sodium dodecyl sulfate)
and 5 mL 100% glycerol) at 1:1 ratio. Load the sample onto the gel with PageRuler™️ Prestained
Protein Ladder and run at 120 V for 90 min. The SDS-Page running buffer was prepared as 25
mM Tris-base, 192 mM glycine, and 0.01 % SDS.
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Fix the gel in 50% (v/v) methanol and 10% (v/v) glacial acetic acid for 5-10 min and then stain
the gel in 50% (v/v) methanol, 10% (v/v) glacial acetic acid and 0.1% (v/v) Coomassie brilliant
blue R-250 for at least 30 mins. Destain the gel with 40% (v/v) methanol and 10% (v/v) glacial
acetic acid and then visualize the gel using Bio-rad ChemiDoc system.

1.2.5 Radioligand binding assay for 19F compound labeled A2AR
During the preparation of the adenosine A2A receptor described in 1.2.1, took some supernatant
right before the ultracentrifuge step as the A2AR membrane sample and the purified protein as the
A2AR protein sample. Incubate a certain number of labeled proteins based on its concentration
measured by BCA assay with binding buffer (25mM pH 7.4 HEPES, 100mM NaCl) and a series
of hot ligands (3H-CGS21680 for A2AR) for the experimental group, additionally with cold ligand
with a final concentration of 2 μM to ensure the hot ligand competitor been replaced out for the
control group. The experimental group has the same setting except of replacement of the cold
ligand in the control group with the same volume of DMSO. [32] The series hot ligands normally
should be continuing from 0.5 nM, 1 nM, 2.5 nM, 5 nM, 7.5 nM, and 10 nM of CGS21680, but as
well depends on the saturation curve of assessment. [10, 33] We usually use 50 μL as a total
volume and six different concentrations of hot ligands as data points. Incubate the mixture at room
temperature for 2 hours. Of note, the filter paper was pretreated with 0.2% polyethyleneimine PEI.
Pre-wash the membranes with 2 mL binding buffer, vacuum dry and then, load the sample on and
vacuum dry. Wash the sample-loaded membrane via vacuum with three times 4 mL binding buffer.
Measure the radioactivity by soaking the membranes in scintillation liquid via a Beckman Coulter
LS6500 liquid scintillation counter (LSC) immediately, repeat three times, and SD values were
calculated from these measurements. [12]
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1.3 Result and Discussion
Using BTFMA labeled A2AR as a model, the expression and purification of A2AR were confirmed
by the SDS gel as shown in Figure 3. There were three lanes shown in the figure: A 2AR control,
protein after His-tag purification, protein after XAC affinity purification. Then, use the
PageRuler™️ Prestained Protein Ladder to determine the size of the purified protein to confirm that
the purification was succussed. It can also be deduced from the gel image that the efficiency and
necessity of XAC Purification via the reduction of non-specific binding protein shown from the
lane of His-tag to XAC-affinity column purification.

The functionality of the purified receptors was validated by radioligand binding assay as shown in
Figure 4 following.

9

Figure 3. SDS-PAGE of expressed A2AR after His-tag and XAC affinity purification.
SDS-PAGE was performed at 120 V for 90 mins with PageRuler™️ Prestained Protein
Ladder.
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Figure 4. Radio ligand binding saturation assay results of A2AR. Data processed by
Excel and Prism.
As the method established, we went to evaluate each potential

19 F

compound to determine their

microenvironmental sensitivity as a function of solvent polarity described in section 1.2.2 before
attachment of A2AR_V229C. To evaluate the sensitivity of each potential tag to
microenvironmental changes, a series of methanol/water mixtures were prepared with a range from
(MeOH: H2O = 4) to (MeOH: H2O = 1/4) by creating a polarity screening system, mimicking
micro-electrostatic environmental system. As shown in Figure 5, the red curve represents the
BTFMA. The other compounds are named in an order and their chemical name, structures, and
CAS number can be found in the Table 1. More than 10 compounds exhibited higher sensitivities
to the surrounding environmental changes than the BTFMA, which provided us an enriched pool
in the following experiments. Due to the time limits as a master's student and the difficulty of
receptor preparation, the work is currently being performed by my colleagues.
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A

B

Figure 5. Free tag screening as a function of mixture of methanol : water.
A. Checked compounds are the ones showing the potential better than the BTFMA from the
free tag perspective.
B. Compound structure with their names. (Continues on the next page)
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Figure 5. Free tag screening as a function of mixture of methanol : water.
B. Compound structure with their names. (Continued)
13

1.4 Summary
One of our goals is to obtain a 19F probe better than the current BTFMA tag in probing the GPCR
conformations, through the free tag screening and then receptor conjugation screening. Due to the
time limits, the current research only allowed me to finish the first step of free tag screening using
the solvent polarity as a solvent system, mimicking the microenvironmental changes. The results
indicated more than ten 19F compounds exhibited higher sensitivities than the BTFMA. It is worthy
of note, a domain rotation indicator (TFKE) was developed during this screening process. [25]
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Chapter Two: Preparation of Yeast-derived G proteins
2.1 Introduction
The G protein is also named guanine nucleotide-binding proteins which indicates their ability of
binding to the nucleotides guanosine triphosphate (GTP) and the guanosine diphosphate (GDP).
[17, 31] Some G proteins are small proteins that only have one single subunit, but the one
associates with GPCRs are usually heterotrimeric which have three subunits: α subunit, β subunit,
and γ subunit. The Gα and Gγ are the subunits attached to the plasma membrane by lipid anchors,
while the Gβ usually form a complex with Gγ. [10] And Gα is classified into several families
including Gαi, Gαs, Gα12/13, and Gαq. Different Gα can bind to different GPCRs, for example, Gαs
can interact with the A2AR. The Gα subunit only binds to either GTP or GDP at once which
depends on which state G protein is: GTP binding when G protein is active while GDP binding
indicates G protein inactive. The initial signal received from GPCR will pass to heterotrimeric G
protein, resulting in conformational changes of G proteins and triggers G protein nucleotide
exchanges. [25] The GDP attaches to the α subunit will be replaced by GTP and results in GTPbound Gα and a Gβγ complex dissociates from GPCR. [25] This interaction leads to some activity
like enzyme production, adenylyl cyclase for example, in the downstream signal transduction. The
yeast system has its advantages in expressing G proteins for receptor conformation and dynamics
study using NMR. First, it is easy for manipulation for isotope labeling compared to other
expression systems with a superb GPCR production at are relatively low cost. [28, 34, 35] The P.
pastoris expression system has shown promise in GPCR preparation, with many advantages that
other eukaryotic expression systems cannot match. P. pastoris is simply to modify and high
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productivity in protein expression and it is also known for its capability of protein production,
especially complex proteins. On another side, the expression of GPCR in P. pastoris for structural
study has already been conducted, so P. pastoris has been chosen for the expression of G protein
here.

2.2 Materials and Methods
2.2.1 Plasmid Construction
Plasmid constructs and flowchart of expression are shown in Figure 6 and Figure 7. Gene was
synthesized ahead and intergraded into the genome of P. pastoris by restriction enzymes: BamHI
and NotHI. The A2AR had a size of 35.1 kDa with a TEV protease cleavage site and α-Factor
peptide ahead of it. It also had FLAG and His10 tags at the N- and C- terminal ends, respectively.

Figure 6: The general procedure for G protein prepration. The Gα and Gβγ preparation are
slightly different, which are described in each section.

Compared to the A2AR, Gα and Gβ had 6 × His, Gγ did not have 6 × His gene because it coexpressed with Gβ. All three G subunits had no FLAG tag or α-Factor peptide. Plasmid
sconstructed by inserting target gene(s) into the vector, pPIC3K, using XL-10 Gold as competent
cells. [27] The recombinant plasmids were digested via BamHI-HF and NotI-HF restriction
enzymes in NEB CutSmartBuffer at 37 °C for 2 h and then digested with Quick CIP at 37 °C for
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30 min. The target genes including Gα (10,385 bp) and Gβ (10,447 bp) and Gγ (9,198 bp)
contained BamHI and NotI restriction sites at N- and C- termini respectively and synthesized based
on the P. pastoris codon. [36] The codon-optimized genes were also treated with BamHI-HF
and NotI-HF restriction enzymes in NEB CutSmartBuffer at 37 °C for 2 h. The digested gene
fragments and recombinant vector were confirmed by DNA electrophoresis and purified via
QIAquick Gel Extraction Kit. Measure the concentration using NanoDrop ™️ Lite

Figure 7: Reconstructed plasmids of Gα, Gβ and Gγ
spectrophotometer before ligating them using T4 DNA Ligase with NEB T4 DNA Ligase Buffer
at room temperature (20 °C) for 2 h or 4 °C overnight. Ligation product stored at -20 °C if not
immediate use.

2.2.2 DNA gel electrophoresis
Using the Bio-rad Agarose Powder make 1% DNA gel by completely dissolving it into TAE
electrophoresis buffer (Thermo Fisher). Add ethidium bromide (EtBr) to a final concentration of
approximately 0.5 μg/mL to allow the visualization of DNA under ultraviolet (UV) light. Pouring
complete dissolved agarose into well with well combs to cool down. Put the solidified gel into the
gel box and fill it with TAE electrophoresis buffer. Mix the sample with DNA 6 × gel loading dye
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(Thermo Fisher) and load into well same as a molecular weight ladder. Run the gel at 70V for 2040 mins and visualize the gel under UV lights.

2.2.3 G protein expression
Ligation products, constructed plasmid containing Gα or Gβγ, were amplified using XL-10 Gold
competent cells. [37] The constructed plasmids were linearized by the PmeI enzyme in NEB
CutSmart® Buffer at 37 °C for at least 2h. Two times volume ethanol was added to the linearized
plasmid and incubate on ice for 5 min. Then centrifuged at 4 °C at 16,200 × g for 10 min and
discarded the supernatant. The fume hood dries the linearized plasmid before added water to
dissolve it. Around dissolved in distilled deionized water, 10 μg linearized plasmid was mixed
with P. pastoris competent cells to perform electroporation under 1,500 V charging voltage, 25 μF
capacitance, and 400 Ω resistance. Right after the electroporation, 1 mL of ice-cold 1 M sorbitol
was added and incubated at 30 °C for 3 h without shaking. Spread the transformed cells on YNBD
(1.34% yeast nitrogen-based w/o amino acid, 0.0004% D-Biotin, and 1% dextrose) plates. As
shown in Figure 6, the colonies grown on the YNBD plates picked up and cultured on YPD plates
with gradient G418 concentrations starting from 1 mg/mL G418 to 4 mg/mL for subsequent
screening.[27]

A single colony derived stock spread on YPD (1% (w/v) yeast extract, 2% (w/v) peptone and 2%
(w/v) glucose) plates containing 1mg/mL G418 was inoculate into 4 mL YPD medium and
cultured at 30 °C overnight with shaking (275 rpm). Then, transferred into 200 mL BMGY (1%
(w/v) yeast extract, 2% (w/v) peptone, 1.34% (w/v) YNB (yeast nitrogen base) without amino
acids, 0.00004% (w/v) glycerol and 0.1 M PB (phosphate buffer) pH 6.5) medium in 14 mL Falcon
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tubes at 30 °C for at least 24 h with shaking (275 rpm) until the absorbance of A595 nm in the range
of 2 to 6. The medium was then transferred into 1L BMMY medium (1% (w/v) yeast extract, 2%
(w/v) peptone, 1.34% (w/v) YNB (yeast nitrogen base) without amino acids, 0.00004% (w/v)
biotin, 0.1 M PB (phosphate buffer) pH 6.5, 0.04% (w/v) histidine, 3% (v/v) DMSO and 10 mM
theophylline) at 20 °C for 60 h with shaking (275 rpm). Methanol (0/5% (v/v)) was added into the
medium every 12 h to induce the Gα or Gβγ expression. [23, 27]

Similar to shown in Figure 2, the cell pellets were collected by centrifuge at 3,800 × g for 10 min
at 4 °C in 400 mL centrifuge bottles and then washed with G protein washing buffer P1 (50 mM
HEPES, pH 8.0). Then the cell pellets were resuspended into G Protein Lysis buffer P2 (50 mM
HEPES, pH 8.0, 10% Glycerol, 100 mM NaCl) at a ratio of four times the volume of cell pellets
itself. The cells in P2 were broken via Microfluidizer for four cycles on the ice at 15,000 psi and
centrifuge at 9,720 × g for 30 min at 4 °C in 250 mL centrifuge bottles to get rid of cell debris. [27,
28]

2.2.4 Gα proteins purification
The supernatant bind to the pre-balanced Talon Resin for 2 h at 4 °C with. The amount of resin
usage for a 6 g membrane should be around 2 mL. Then, the Talon Resin was packed onto a
column and performed purification. First, using G protein washing buffer P1 washed on column 5
column volumes and then eluted the expressed protein, which supposed to be Gα (45.7 kDa),
strategically recycling using 10 mL G protein elution buffer P3 (50 mM HEPES, pH 8.0 and 300
mM imidazole) at a gravity rate. [29] Use Ultra-15 Centrifuge filters 3K to concentrate the
collected eluted protein to 2 mL and ready to load onto the FPLC system. The FPLC system was
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balanced in advance with Q Buffer A – Gα (50 mM HEPES, pH 8.0, 50 μM GDP and 1mM MgCl2),
and the elution process was done by both Q Buffer A-Gβγ and Q Buffer B – Gα (50 mM HEPES,
pH 8.0, 50 μM GDP, 1mM MgCl2 and 1,000 mM NaCl) under the condition of flow rate: 1.0
mL/min; maximum column pressure: 0.5 MPa and fraction: 2.0 mL. Based on the result elution
profile, the corresponding fractions were collected and concentrated. The BCA kit was used to
identify the concentration of the Gα.

2.2.5 G proteins purification
The supernatant bind to the pre-balanced Talon Resin for 2 h at 4 °C with shaking. The amount of
resin usage for a 6 g membrane was around 2 mL. Then, the Talon Resin was packed onto a column
and performed purification. First, using G protein washing buffer P1 washed on column 5 column
volumes and then eluted the expressed proteins, which was supposed to be Gβ (38.7 kDa) and Gγ
(7.6 kDa), strategically recycling using 10 mL G protein elution buffer P3 (50 mM HEPES, pH
8.0 and 300 mM imidazole) at a gravity rate. [29] Use Ultra-15 Centrifuge filters 3K to concentrate
the collected eluted receptors to 2 mL and ready to load onto the FPLC system. The FPLC system
was balanced in advance with Q Buffer A – Gβγ (50 mM HEPES, pH 8.0 or 20 mM Bis-Tris, pH
6.5), and the elution process was done by both Q Buffer A-Gβγ and Q Buffer B – Gβγ (50 mM
HEPES, pH 8.00 or 20 mM Bis-Tris, pH 6.5 and 1,000 mM NaCl) under the condition of flow rate:
1.0 mL/min; maximum column pressure: 0.5 MPa and fraction: 2.0 mL. Based on the result elution
profile, the corresponding fractions were collected and concentrated. The BCA kit was used to
determine the concentration of Gβγ.
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2.2.6 SDS-PAGE and Western-Blotting
Preparing the SDS-PAGE gel based on the size of protein and our choice was 12% for separating
gel. The purified protein mixture to the 2 × loading (50 mL receipt: 1 mg bromophenol blue, 12.5
mL 1.5 M Tris-HCl, pH 6.8, 2.5 mL 10% SDS (sodium dodecyl sulfate) and 5 mL 100% glycerol)
at 1:1 ratio. Load the sample onto the gel with PageRuler™️ Prestained Protein Ladder and run at
120 V for 90 min. The SDS-Page running buffer was prepared as 25 mM Tris-base, 192 mM
glycine, and 0.01 % SDS. Fixed the gel in 50% (v/v) methanol and 10% (v/v) glacial acetic acid
for 5-10 min and then stained the gel in 50% (v/v) methanol, 10% (v/v) glacial acetic acid and 0.1%
(v/v) Coomassie brilliant blue R-250 for at least 30 mins. Destained the gel with 40% (v/v)
methanol and 10% (v/v) glacial acetic acid and then visualized the gel using Bio-rad ChemiDoc
system.

The Western-blotting gel was run side by side with SDS-Page gel in order to have identical
localization of protein bands on gels. Prepare the PVDF (polyvinylidene fluoride) membrane by
cutting it into the same size as the filter paper and larger than the SDS-Page gel. Presoak the PVDF
into the methanol for 2 min then submerge the PVDF in ice-cold Western blot transfer buffer (25
mM Tris, 192 mM glycine, and 0.1% SDS) for 5 min. After running the gel at 120 V for 90 min,
assemble the gel and PVDF membrane like a sandwich using filter paper and a sponge as the bread.
Run blot at 100 V for 90 min or 300 mA for 75 min and make sure the negative side of the machine
matches the gel side. The time and voltage can be slightly optimized base on the condition until
the protein is adder is fully transferred. Submerge membrane in blocking buffer (125 mM NaCl,
25 mM Tris base, pH 7.5, 0.3% Tween-,20 and 3% non-fat milk) for 1 h at room temperature with
shaking and then discard the blocking buffer. Apply antibody incubation buffer (Anti-His/Anti-
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Flag antibody diluted to 1:2000 with blocking buffer) at room temperature with shaking for 1 h
and collect the antibody incubation buffer and store at -20 °C for reuse. Wash the PVDF membrane
with washing buffer (125 mM NaCl, 25 mM Tris base, pH 7.5, 0.3% Tween-20) for 5 min at room
temperature with shaking followed by distilled water twice. The membrane was finally visualized
by Super Signal West Pico Plus Chemiluminescent Substrate (usually 6 mL in total should be
enough for one membrane) after shaking at room temperature for 5 min.

2.3 Result and Discussion
2.3.1 Gα proteins purification
The Gα subunit was around 45 kDa which fits the expectations. Both the left gel on Figure 8:
His-tag fraction, and the right gel: concentrated ones, did have the intense band around that
size. The FPLC curve in the middle showed the elution program and resultant elution profile for
the Gα.
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Figure 8. Purification results shown in FPLC curves with gel confirmations of yeast-derived
Gα
A. His tag purification of yeast-derived Gα show in SDS-PAGE
B. FPLC resulting curve for the Gα
C. Collected FPLC fractions based on the result curve. Yeast-derived Gα shown in SDS-PAGE.

2.3.2 G proteins purification
The Gβ subunit should be slightly below the 40 KDa band on the ladder while the complex of Gβγ
should be around 45 kDa which fits between the 40 kDa and 50 kDa bands in the ladder lane.
In Figure 9, the FPLC curves presented for Gβγ and the SDS Page showed the band stands for the
concentrated fractions from FPLC. The two peaks in the FPLC result curve also indicates there are
both Gβ and Gβγ complex showing up in the purified protein.
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Figure 9. Purification results shown in FPLC curves with gel confirmations of yeast-derived
Gβγ
A. FPLC resulting curve for Gβγ
B. Purification of yeast-derived Gβγ shown in SDS-PAGE
2.4 Summary
This project enabled us to establish two protocols in preparing yeast-based G proteins, including
G and G, though their functionality still needs to be further validated using various tools such
as observation of radioligand bindings of the receptor when they engage the receptors.
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Conclusion
One of the goals of this thesis is to obtain a desirable 19F chemical tag better than the BTFMA in
probing the GPCR conformational states and dynamics, which is partially accomplished here. Due
to the limitation of time, the subsequent work in this direction is ongoing by other lab members.

As part of the effort for this thesis, we also successfully established platforms of expressing G
and G using the yeast-based expression system, which will have significance to investigate the
conformational transitions and dynamics of these G proteins by isotopically labeling each of G
proteins while interacting with the receptors along with associated nucleotide exchanges.
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Appendix A: Supplementary Tables
Table A1: Names and CAS numbers for the Trifluorinated Compounds Used in This Study
Names

CAS

0

2-Bromo-N-(4-(trifluoromethyl)phenyl)acetamide

3823-19-6

1

4-Bromo-2-(trifluoromethyl)phenoz

50824-04-9

2

1-(4-Bromophenyl)-2,2,2-trifluoroethanamine

843608-46-8

3

2,6-Dibromo-4-(trifluoromethoxy)anilinz

88149-49-9

4

4-Bromo-N-(2,2,2-trifluoro-1-phenylethyl)benzamide

R269077

5

1,1-Dibromo-3,3,3-trifluoroacetone

431-67-4

6

4-Amino-3-iodobenzotrifluoride

163444-17-5

7

Potassium (bromomethyl)trifluoroborate

888711-44-2

8

2-Thenoyltrifluoroacetonez

326-91-0

9

2-Amino-5-bromobenzotrifluozide

445-02-3

11 3-Bromo-1,1,1-trifluoroacetone

431-35-6

12 2-Bromo-3,3,3-trifluoro-1-propene

1514-82-5

13 4-Bromo-3-nitrobenzotrifluoride

349-03-1

14 2-(Trifluoromethoxy)iodobenzene

175278-00-9

15 4-[3-(Trifluoromethyl)-3H-diazirin-3-yl]benzyl Bromide

92367-11-8

16 5-Bromo-2-(trifluoromethyl)pyridine

436799-32-5

17 2-Bromo-5-(trifluoromethyl)aniline

454-79-5
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Table A1(Continued)
18 3-Bromo-1,1,1-trifluoropropan-2-ol

431-34-5

19 4'-Bromo-2,2,2-trifluoroacetophenone

16184-89-7

20 3-Bromo-1-(2,2,2-trifluoroethyl)pyrazole
21 4-Bromo-3-(trifluoromethyl)aniline

1354706-174
393-36-2

22 1-Iodo-3-(trifluoromethyl)benzene

401-81-0

23 1-(4-Bromo-thiophen-2-YL)-2,2,2-trifluoro-ethanone

1252046-142

24 3,3,3-Trifluoro-N-(2-iodophenyl)-2-(trifluoromethyl)propanamide
25 4-Bromo-1,1,1-trifluoro-2-(trifluoromethyl)butane

203303-02-0

26 4-iodo-1-[2,2,2-trifluoro-1-(4-iodophenyl)-1(trifluoromethyl)ethyl]benzene
27 1-(4-Bromophenyl)-4,4,4-trifluorobutane

55100-57-7

28 Potassium 4-bromophenyltrifluoroborate

374564-35-9

29 5-Bromo-3-(trifluoromethyl)pyridin-2-amine

79456-34-1

30 3,5-bis(trifluoromethyl)phenylacetyl chloride

174083-39-7

31 4-Fluoro-3-(trifluoromethyl)benzyl bromide

184970-26-1

32 5-Bromo-2-nitrobenzotrifluoride

344-38-7

33 2-Amino-3-bromo-5-(trifluoromethyl)pyridine

79456-30-7

34 3-Chloro-4-iodobenzotrifluoride

141738-80-9

35 Potassium trifluoro(iodomethyl)borate

888711-47-5

36 1-Fluoro-4-(trifluoromethylthio)benzene

940-76-1

37 4-Ethoxy-3-(trifluoromethyl)benzyl bromide
38 3-Chloro-4-(trifluoromethyl)benzyl bromide

1206593-307
361393-92-2

40 4-IodophenylsμLfur Pentafluoride

286947-68-0

18931-61-8
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